Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CanBiotech is an open innovation and market access platform that serves the biotechnology, pharmaceutical, and medical technology sectors. Founded to facilitate cross-border partnerships, the company provides a B2B marketplace, market entry strategies, and distributor management services, with a particular focus on connecting North American innovators with the Asia-Pacific region. CanBiotech also acts as a master distributor for specialized healthcare products, including advanced wound care gels and laser therapy systems. Through its integrated platform, it helps life science companies navigate regulatory complexities and accelerate the commercialization of medical technologies globally. The company's mission is to bridge the gap between scientific innovation and international market success.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CanBiotech.